- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
GEMS sees healthy growth in 1999
GE Medical Systems garnered praise when GE announced its fiscal 1999 financial results. The Fairfield, CT, conglomerate said that acceptance of its Six Sigma-designed products caused its medical business to grow by 25% for the year. Six Sigma is
GE Medical Systems garnered praise when GE announced its fiscal 1999 financial results. The Fairfield, CT, conglomerate said that acceptance of its Six Sigma-designed products caused its medical business to grow by 25% for the year. Six Sigma is GEs quality improvement program, which is being applied company-wide.
Many of GEs 1999 accomplishments culminated at last Decembers RSNA conference. There it completed its acquisition of OEC Medical Systems and introduced a new high-field open MRI system, GE Sigma OpenSpeed. Following the meeting, GE won a recommendation from a Food and Drug Administration panel for clearance of its digital mammography unit, Senographe 2000D (SCAN 1/12/00, 11/24/99, and 9/18/99).
For the year, GE reported revenues of $112 billion, up 11% compared with $100 billion in 1998. The company posted earnings of $10.7 billion, up 15% from 1998s $9.3 billion. GE did not break out sales and earnings figures for GE Medical Systems, other than to report on the businesss overall growth.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
